Who owns JANUX THERAPEUTICS INC?
- Ticker: JANX
- CUSIP Number: 47103j105
Tip: Access positions for across all investors
Analyze quarterly positions in Janux Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Janux Therapeutics stock
Who bought or sold JANUX THERAPEUTICS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
RA Capital Management | 9.2M | $98M | 0% | Dec 2023 |
|
BVF | 4.6M | $49M | 0% | Dec 2023 |
|
OrbiMed Advisors | 3.3M | $36M | 0% | Dec 2023 |
|
Citadel Advisors | 3.1M | $34M | -9% | Dec 2023 |
|
Henderson Group | 1.9M | $21M | -7% | Dec 2023 |
|
Vanguard Group | 980k | $11M | 4% | Dec 2023 |
|
Samsara BioCapital | 360k | $3.9M | 0% | Dec 2023 |
|
Alyeska Investment Group | 198k | $2.1M | 13% | Dec 2023 |
|
Millennium Management | 72k | $771k | -29% | Dec 2023 |
|
Squarepoint Ops | 61k | $656k | 475% | Dec 2023 |
|
HPM Partners | 61k | $654k | 100% | Dec 2023 |
|
Zacks Investment Management | 59k | $631k | 100% | Dec 2023 |
|
Bank of New York Mellon | 53k | $566k | -1% | Dec 2023 |
|
Janney Montgomery Scott | 52k | $553k | 100% | Dec 2023 |
|
DekaBank Deutsche Girozentrale | 50k | $579k | 0% | Dec 2023 |
|
Barclays | 48k | $511k | 166% | Dec 2023 |
|
Charles Schwab Investment Management | 46k | $495k | -5% | Dec 2023 |
|
Two Sigma Investments | 44k | $473k | 129% | Dec 2023 |
|
Bank of America Corporation | 44k | $470k | 43% | Dec 2023 |
|
Goldman Sachs Group | 40k | $429k | 175% | Dec 2023 |
|
Swiss National Bank | 32k | $341k | 39% | Dec 2023 |
|
Rhumbline Advisers | 26k | $280k | -2% | Dec 2023 |
|
Two Sigma Advisers | 24k | $253k | 100% | Dec 2023 |
|
Credit Suisse | 18k | $197k | 17% | Dec 2023 |
|
Jpmorgan Chase & Co | 18k | $190k | -88% | Dec 2023 |
|
Alliancebernstein | 17k | $186k | 3% | Dec 2023 |
|
State of Wisconsin Investment Board | 15k | $162k | 44% | Dec 2023 |
|
Connor, Clark & Lunn Investment Management | 13k | $138k | 100% | Dec 2023 |
|
MetLife Investment Advisors | 11k | $114k | 0% | Dec 2023 |
|
Old Well Partners | 10k | $111k | 0% | Dec 2023 |
|
Legal & General Group | 9.9k | $106k | 0% | Dec 2023 |
|
SG Americas Securities | 9.3k | $100k | 100% | Dec 2023 |
|
American International | 8.6k | $92k | 0% | Dec 2023 |
|
Exchange Traded Concepts | 7.5k | $284k | -47% | Mar 2024 |
|
Deutsche Bank Aktiengesellschaft | 7.0k | $75k | 0% | Dec 2023 |
|
Allspring Global Investments Holdings | 6.3k | $239k | -76% | Mar 2024 |
|
China Universal Asset Management | 5.3k | $57k | 100% | Dec 2023 |
|
Wells Fargo & Company | 5.3k | $57k | 24% | Dec 2023 |
|
New York State Common Retirement Fund | 5.1k | $54k | -1% | Dec 2023 |
|
Royal Bank of Canada | 4.7k | $51k | 38% | Dec 2023 |
|
Citigroup | 3.8k | $41k | 681% | Dec 2023 |
|
NISA Investment Advisors | 2.7k | $29k | 10740% | Dec 2023 |
|
Lazard Asset Management | 1.7k | $0 | 4% | Dec 2023 |
|
Summit Investment Advisors | 1.7k | $18k | 0% | Dec 2023 |
|
Amalgamated Bank | 1.6k | $17k | -10% | Dec 2023 |
|
Metropolitan Life Insurance Company | 1.0k | $11k | 0% | Dec 2023 |
|
Cutler | 400.00 | $15k | 100% | Mar 2024 |
|
Raleigh Capital Management | 270.00 | $2.9k | 100% | Dec 2023 |
|
Nelson, Van Denburg & Campbell Wealth Management | 243.00 | $2.6k | 100% | Dec 2023 |
|
Fortitude Family Office | 207.00 | $7.8k | -13% | Mar 2024 |
|
Advisory Services Network | 134.00 | $1.4k | 100% | Dec 2023 |
|
Us Bancorp | 90.00 | $965.997000 | 0% | Dec 2023 |
|
Hanson McClain Advisors | 56.00 | $600.997600 | 100% | Dec 2023 |
|
GAMMA Investing | 18.00 | $678.000600 | 100% | Mar 2024 |
|
CWM | 1.00 | $0 | 100% | Mar 2024 |
|
Huntington National Bank | 1.00 | $11.000000 | 100% | Dec 2023 |
|
Who sold out of Janux Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Bank Of Montreal | Sep 2023 | 98k | $1.1M |
Trexquant Investment | Sep 2023 | 12k | $119k |
Corton Capital | Sep 2023 | 11k | $112k |